To the Editor: There are misleading recommendations in the CurrentConcepts article entitled "Treatment of Male Infertility," byStuart S. Howards (Feb. 2 issue).1 Dr. Howards recommends theuse of an inappropriate dosage of metronidazole to treat trichomonasinfections. The article states that 2 g of metronidazole shouldbe administered orally four times a day for 10 days. In fact,the recommended dose for trichomonas infections in both menand women is either a single oral dose of 2 g or a dose of 500mg orally two times a day for seven days.2 In addition, thefinal sentence of the section entitled "Infection" can be easilymisinterpreted. As the sentence reads currently, either doxycyclineor metronidazole is recommended for mycoplasma, ureaplasma,or trichomonas infections. In fact, the treatment for mycoplasmaor ureaplasma is indeed doxycycline, and the treatment for trichomonasis metronidazole. Doxycycline is not recommended for trichomonasinfections.
Aside from these two issues, I found Dr. Howards's article quiteinformative.
Harold C. Wiesenfeld, M.D., C.M. MageeWomens Hospital Pittsburgh,PA 15213-3180
References
Howards SS. Treatment of male infertility. N Engl J Med 1995;332:312-317. [Free Full Text]
To the Editor: In discussing abnormalities of semen, Dr. Howardserroneously states that the normal ejaculate is liquefied within20 minutes by proteolytic enzymes secreted by the seminal vesicles.In fact, the seminal vesicles provide the substrate for seminalcoagulation. The proteolytic enzyme causing sequential liquefactioncomes from the prostate.1 This proteolytic agent has recentlybeen identified as prostate-specific antigen, a glycoproteinkallikrein-like serine protease derived from the secretory layerof prostatic epithelium.2 Prostate-specific antigen is alsofound in high concentrations in specimens of human semen.
Richard D. Amelar, M.D. Lawrence Dubin, M.D. Cy Schoenfeld,Ph.D. New York University Medical Center New York, NY 10016
References
Amelar RD. Coagulation, liquefaction and viscosity of human semen. J Urol 1962;87:187-190. [Medline]
Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-923. [Medline]
To the Editor: In men with normospermia, sperm counts decreasesignificantly with frequent ejaculation. In men with oligospermiaor asthenospermia, the effect of sequential ejaculation wasgenerally assumed to be similar or even greater. Thus, in orderto "save up sperm," the usual recommendation to couples tryingto conceive was to have intercourse every 48 hours during thetime of expected ovulation, as stated by Howards in his recentreview of the treatment of male infertility.
However, recent results from different laboratories suggestthat this is a myth.1,2,3,4 We recently demonstrated in a cohortof 576 men that, in contrast to men with normospermia, mostmen with oligospermia or asthenospermia have a different responseto sequential ejaculation.4 As compared with the first ejaculate,in most of these men the second successive ejaculate, obtainedafter an interval of 1 to 4 or 24 hours, contained a similaror an even greater number of motile sperm. Therefore, poolingsequential ejaculates can significantly increase the total motile-spermcount by 67 to 233 percent of that of the first ejaculate.
The current trend in the management of severe male infertilityis to use assisted-reproduction techniques with or without gametemicromanipulation. These procedures involve some risks, arepsychologically stressful to patients, and are expensive andtime consuming. Although it is not clear how many sperm areneeded for a man to be fertile, higher sperm counts are associatedwith an increased chance that an infertile couple will conceiveand with increased success rates of in vitro fertilization.On the basis of these recent studies,1,2,3,4 we suggest changingthe usual recommendation made to infertile men who try to conceive.4,5Men with oligospermia or asthenospermia may increase their fertilitypotential, as assessed by the total motile-sperm count, by havingtimed intercourse every day or even twice a day at the timeof expected ovulation.
Ilan Tur-Kaspa, M.D. Yasmin Maor, M.D. Jehoshua Dor, M.D. ChaimSheba Medical Center Tel Hashomer 52621, Israel
References
Tur-Kaspa I, Dudkiewicz A, Confino E, Gleicher N. Pooled sequential ejaculates: a way to increase the total number of motile sperm from oligozoospermic men. Fertil Steril 1990;54:906-909. [Medline]
Hornstein MD, Cohen JN, Thomas PP, Gleason RE, Friedman AJ, Mutter GL. The effect of consecutive day inseminations on semen characteristics in an intrauterine insemination program. Fertil Steril 1992;58:433-435. [Medline]
Matilsky M, Battino S, Ben-Ami M, Geslevich Y, Eyali V, Shalev E. The effect of ejaculatory frequency on semen characteristics of normozoospermic and oligozoospermic men from an infertile population. Hum Reprod 1993;8:71-73. [Free Full Text]
Tur-Kaspa I, Maor Y, Levran D, Yonish M, Mashiach S, Dor J. How often should infertile men have intercourse to achieve conception? Fertil Steril 1994;62:370-375. [Medline]
Tur-Kaspa I, Maor Y, Dor J, Mashiach S. Frequency of intercourse for couples trying to conceive. Lancet 1994;344:766-766. [Medline]
Dr. Howards replies:
To the Editor: I thank Amelar et al. for correcting the errorin my discussion of the source of proteolytic enzymes in thesemen. I also thank Dr. Wiesenfeld for his appropriate correctionsof the dose and use of metronidazole. Finally, it is possiblethat Tur-Kaspa et al. are correct, and their conclusions arecertainly consistent with their referenced work. However, uncertaintyremains about how often infertile men should have intercourseto maximize the chance of conception. Their study1 by no meansoffers enough data to be certain about this point. There isno consensus whether their approach or the one I recommendedis correct.
Stuart S. Howards, M.D. University of Virginia Health SciencesCenter Charlottesville, VA 22908
References
Tur-Kaspa I, Maor Y, Levran D, Yonish M, Mashiach S, Dor J. How often should infertile men have intercourse to achieve conception? Fertil Steril 1994;62:370-375.